The Global Alzheimer's Platform Foundation(R) (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback